AI for Predictive Healthcare
Tempus, founded by Eric Lefkofsky in the US, uses AI to analyze clinical and molecular data, helping doctors personalize cancer treatment plans. Their platform aims to improve patient outcomes by predicting how individuals will respond to specific therapies. Tempus recently raised $200 million in Series G funding.
